[Clinical and immunologic comparison in chronic ischemic brain disease secondary to atherosclerosis]

Insights

Cerebral atherosclerosis (CA) triggers autoimmune responses in patients with cerebrovascular disease (CVD). These immune reactions correlate with disease progression and lipid metabolism, highlighting CA

Area of Science:

  • Neuroscience
  • Immunology
  • Cardiovascular Research

Background:

  • Cerebral atherosclerosis (CA) is a significant risk factor for cerebrovascular disease (CVD).
  • Understanding the immunological underpinnings of CA-related CVD is crucial for risk assessment and management.

Purpose of the Study:

  • To evaluate the role of cerebral atherosclerosis (CA) as a risk factor in the development and progression of atherosclerotic cerebrovascular disease (CVD).
  • To investigate autoimmune reactions against cerebral vessels in patients with CVD.

Main Methods:

  • Studied immunoreactions (humoral and cellular) to atherosclerotic cerebral vessel antigens in 330 CVD patients (aged 46-82).
  • Compared patient reactions to control groups (healthy young and age-matched asymptomatic individuals).
  • Assessed correlations between autoimmune reactions, CVD stage, lesion location, and lipid metabolism parameters.

Main Results:

  • Patients with CVD exhibited significantly heightened autoimmune reactions to atherosclerotic cerebral vessel antigens compared to controls.
  • Reaction intensity increased with CVD progression and was more pronounced in areas with predominant atherosclerotic lesions.
  • Strong correlations were found between autoimmune reactions and lipid metabolism parameters (cholesterol, triglycerides), indicating a link to hyperlipidemia.

Conclusions:

  • Autoimmune responses against cerebral vessels are prevalent in atherosclerotic CVD and correlate with disease severity and lipid profiles.
  • These findings suggest that cerebral vessel antigenicity is linked to the degree of atherosclerotic lesion and may play a role in CVD pathogenesis.
  • Cerebral atherosclerosis (CA) contributes to cerebrovascular disease (CVD) through associated autoimmune reactions.